TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-18

Archived explainer. For the current picture see today's LYCA page.

Why Is LYCIA THERAPEUTICS I (LYCA) Stock Up Today?

By the Top Tier Newswire AI Desk · November 18, 2026 at 12:14 AM ET · reviewed against 11 wire stories

LYCIA THERAPEUTICS I (LYCA) is up +8.07% in the latest session. Our newswire has captured 11 stories on LYCA across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 64/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Lycia Therapeutics (LYCA) shares rose 8.07% to close at $30.92. The primary driver for the move was a wave of new analyst coverage, with four firms initiating positive ratings on the stock within the last 36 hours.

What Happened

Jefferies initiated coverage on Lycia Therapeutics with an Outperform rating and a price target of $50. Guggenheim also started coverage with a Buy rating, citing the potential of the food allergy market. TD Cowen initiated the stock with a Buy rating, and LifeSci Capital began coverage with an Outperform rating. This cluster of positive initiations occurred as the company prepared to present at the 2026 Jefferies Global Healthcare Conference.

What The Data Shows

The stock printed eight fresh 52-week highs on November 17, 2026. Over the last eight sessions, the share price moved up 1.4%, rising from $30.50 to the current level of $30.92. The company currently has a market capitalization of $1.8 billion, with a 52-week trading range of $22.19 to $36.49. Insider activity has been exclusively positive over the last 90 days, with three buys totaling $38.5 million and no sells. The most recent transaction was recorded on November 4, 2026. Venrock Healthcare Capital Partners III, L.P., a 10% holder, executed purchases on November 2, October 28, and October 23, 2026.

What To Watch

Investors will monitor the company’s presentation at the 2026 Jefferies Global Healthcare Conference for further updates on its pipeline and commercial strategy.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

LYCA by the numbers

Last: $30.92Session: +8.07%7 sessions: +3.26%Coverage: 11 stories / 4 sourcesAI sentiment: 64/100 (bullish)Mkt cap: $1.8B52w: $22.19 to $36.49
LYCA · Nov 18 session (5-min) · +1.39% vs prior close · updated 8:53 PM ET
$30.56$31.57$32.57prev close $30.92$31.359:30 AM11:07 AM12:45 PM2:22 PM4:00 PM9:30 AM · $31.079:35 AM · $31.219:40 AM · $31.019:45 AM · $31.029:50 AM · $31.029:55 AM · $31.2510:00 AM · $31.2510:05 AM · $32.1110:10 AM · $32.0410:15 AM · $32.4010:20 AM · $32.4010:25 AM · $32.4710:30 AM · $31.9810:35 AM · $32.1310:40 AM · $32.1210:45 AM · $31.9510:50 AM · $31.8510:55 AM · $32.0211:00 AM · $31.6511:05 AM · $31.7511:10 AM · $31.4011:15 AM · $31.5111:20 AM · $31.4811:25 AM · $31.3611:30 AM · $31.3611:35 AM · $31.3611:40 AM · $31.3111:45 AM · $31.3911:50 AM · $31.7211:55 AM · $31.3112:00 PM · $31.5512:05 PM · $31.3912:10 PM · $31.2112:15 PM · $31.1812:20 PM · $31.2912:30 PM · $32.0312:35 PM · $31.3412:40 PM · $31.5812:45 PM · $31.2412:50 PM · $31.3612:55 PM · $31.361:00 PM · $31.051:05 PM · $31.291:10 PM · $31.291:20 PM · $31.381:25 PM · $31.161:30 PM · $31.381:35 PM · $31.161:40 PM · $31.061:45 PM · $31.061:50 PM · $31.151:55 PM · $30.842:00 PM · $30.802:05 PM · $30.772:10 PM · $30.672:15 PM · $30.782:20 PM · $30.852:25 PM · $30.812:30 PM · $30.832:35 PM · $30.852:40 PM · $30.842:45 PM · $31.062:50 PM · $30.872:55 PM · $31.103:00 PM · $31.013:05 PM · $31.073:10 PM · $31.073:15 PM · $31.023:20 PM · $31.063:25 PM · $30.993:30 PM · $30.953:35 PM · $30.953:40 PM · $30.903:45 PM · $31.163:50 PM · $31.213:55 PM · $31.504:00 PM · $31.35
AI sentiment, last 36h · averaged over 11 stories · 64/100 bullish
AI sentiment 64/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishThe Fly · sentiment 63 · Lycia Therapeutics initiated with a Buy at JefferiesThe Fly · 63Lycia Therapeutics initiated with a Buy at JefferiesThe Fly · sentiment 63 · Lycia Therapeutics initiated with a Buy at TD CowenThe Fly · 63Lycia Therapeutics initiated with a Buy at TD CowenInvesting.com Analyst Ratings · sentiment 63 · Guggenheim initiates Lycia Therapeutics stock with buy ratingInvesting.com Analyst Ratings · 63Guggenheim initiates Lycia Therapeutics stock with buy ratingThe Fly · sentiment 63 · Lycia Therapeutics initiated with a Buy at GuggenheimThe Fly · 63Lycia Therapeutics initiated with a Buy at GuggenheimThe Fly · sentiment 64 · Guggenheim starts Lycia Therapeutics with a Buy on food allergy market potentialThe Fly · 64Guggenheim starts Lycia Therapeutics with a Buy on food allergy market potentialThe Fly · sentiment 63 · Lycia Therapeutics initiated with an Outperform at LifeSci CapitalThe Fly · 63Lycia Therapeutics initiated with an Outperform at LifeSci CapitalGuruFocus · sentiment 61 · LYCA Initiated by Jefferies -- Price Target Announced at $50GuruFocus · 61LYCA Initiated by Jefferies -- Price Target Announced at $50Investing.com Markets · sentiment 72 · Why is Lycia Therapeutics stock surging today?Investing.com Markets · 72Why is Lycia Therapeutics stock surging today?
3d agoInvesting.com MarketsBULLISH 72General

Why is Lycia Therapeutics stock surging today?

Why is Lycia Therapeutics stock surging today?

3d agoGuruFocusBULLISH 61Analyst

LYCA Initiated by Jefferies -- Price Target Announced at $50

3d agoThe FlyBULLISH 63Analyst

Lycia Therapeutics initiated with an Outperform at LifeSci Capital

3d agoThe FlyBULLISH 64Analyst

Guggenheim starts Lycia Therapeutics with a Buy on food allergy market potential

3d agoThe FlyBULLISH 63Analyst

Lycia Therapeutics initiated with a Buy at Guggenheim

3d agoInvesting.com Analyst RatingsBULLISH 63Analyst

Guggenheim initiates Lycia Therapeutics stock with buy rating

Guggenheim initiates Lycia Therapeutics stock with buy rating

3d agoThe FlyBULLISH 63Analyst

Lycia Therapeutics initiated with a Buy at TD Cowen

3d agoThe FlyBULLISH 63Analyst

Lycia Therapeutics initiated with a Buy at Jefferies

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on LYCA: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier LYCA move explainers: 2026-11-18 · 2026-11-17